March Therapeutics

📍 Cambridge, United States🗓 Founded 2020👥 8 employees💰 Last funded Apr 2020
March Therapeutics aims to revolutionize the discovery and development of novel genetic medicines by pioneering Biomolecular Learning, an evolutionary approach incorporating molecular recording and advanced computing to mine the tree of life for novel protein modalities and optimize them for therapeutic applications.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in March Therapeutics?
March Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did March Therapeutics last raise funding?
The most recent investment in March Therapeutics recorded on gritt.io was in April 2020.
When was March Therapeutics founded?
March Therapeutics was founded in 2020.
What industry is March Therapeutics in?
March Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is March Therapeutics based?
March Therapeutics is headquartered in Cambridge, United States.